NIH Director's Blog

Senate

Congratulations on 2020 Nobel Prize in Chemistry

Posted on October 7th, 2020 by Dr. Francis Collins

Congratulations to Jennifer Doudna and Emmanuelle Charpentier on sharing the 2020 Nobel Prize in Chemistry “for the development of a method for genome editing.” Doudna, a biochemist with the University of California, Berkeley and a genome editing pioneer, has received continuous NIH funding since 1997. Charpentier is a French microbiologist and a fellow genome editing pioneer with the Max Planck Institute for Infection Biology, Berlin, Germany. Here, I am with Doudna on December 12, 2018 during a U. S. Senate NIH Caucus Meeting on CRISPR and Gene Editing. Credit: Berkeley News

Posted In: Director's Album - Photos

Tags: 2020 Nobel Prize in Chemistry, CRISPR, Emmanuelle Charpentier, genome editing, Jennifer Doudna, Max Planck Institute, Senate

Senate Hearing on Vaccines

Posted on September 10th, 2020 by Dr. Francis Collins

Senate Hearing — As always, it was an honor to testify before the U.S. Senate Committee on Health, Education, Labor, and Pension. The title of the hearing was “Vaccines: Saving Lives, Ensuring Confidence, and Protecting Public Health.” Also testifying was Jerome Adams, Surgeon General of the United States. The hearing was held on September 9, 2020 in the Dirksen Senate Office Building, Washington, D.C.

Posted In: Director's Album - Photos

Tags: COVID-19, COVID-19 vaccine, Dirksen Senate Office Building, Jerome Adams, novel coronavirus, pandemic, Senate

Testifying on COVID-19 Vaccine Development

Posted on July 2nd, 2020 by Dr. Francis Collins

Testifying on Vaccine Development for COVID-19 — It was an honor to testify before the U.S. Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on July 2. The topic of the hearing was the President’s plan to develop and distribute a COVID-19 vaccine. Also testifying were Robert Redfield, director of the Centers for Disease Control and Prevention, and Gary Disbrow, acting director of Biomedical Advanced Research and Development Authority (BARDA). The nearly three-hour hearing allowed a productive exchange of information on this critical topic and many of NIH’s high-priority efforts to develop vaccines and therapeutics for COVID-19. Credit: C-Span.

Posted In: Director's Album

Tags: BARDA, CDC, COVID-19, COVID-19 vaccine, Gary Disbrow, novel coronavirus, pandemic, Robert Redfield, SARS-CoV-2, Senate

Blog Archives

Blog Info

Editor

Kendall Morgan, Ph.D.

Comments and Questions

If you have comments or questions not related to the current discussions, please direct them to Ask NIH.

You are encouraged to share your thoughts and ideas. Please review the NIH Comments Policy